Molecular modeling studies and <i>in vitro</i> screening of dihydrorugosaflavonoid and its derivatives against <i>Mycobacterium tuberculosis</i>
作者:Ninad V. Puranik、Pratibha Srivastava、Sagar Swami、Amit Choudhari、Dhiman Sarkar
DOI:10.1039/c8ra00636a
日期:——
Novel drug regimens against tuberculosis (TB) are urgently needed and may be developed by targeting essential enzymes of Mtb that sustain the pathogenicity of tuberculosis. Dihydrorugosaflavonoid interacted with the active pocket of MabA and PanK.